Pfizer Recalls Some Lots Of Blood Pressure Drug Due To Potential Carcinogen

Pfizer Recalls Some Lots Of Blood Pressure Drug Due To Potential Carcinogen

(Reuters) -Pfizer Inc said on Monday it was recalling some lots of blood pressure drug Accuretic and two authorized cheaper versions of the drug due to the presence of elevated levels of a nitrosamine, a potential cancer-causing impurity. Pfizer said https://www.pfizer.com/news/press-release/press-release-detail/pfizer-voluntary-nationwide-recall-lots-accuretictm it has not received any reports of adverse events related to the drug till…

Read More
Analysis - Europe Split On How To Spare Consumers Energy Price Pain

Analysis – Europe Split On How To Spare Consumers Energy Price Pain

By Kate Abnett and Susanna Twidale BRUSSELS/LONDON (Reuters) – Proposals from southern European countries to intervene in energy markets have highlighted the difficulty facing an EU summit this week as it seeks to respond to record prices driven by Russia’s invasion of Ukraine. The 27 EU-member states are responsible for their own national energy policies….

Read More